SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011
7 references·7 citing·44 second hop
Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011 (2015)Trends in the Cost and Use of Targeted Ca…The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts (2013)The price of drugs for chroni…Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)Cost Sharing and Adherence to…Projections of the Cost of Cancer Care in the United States: 2010-2020 (2011)Projections of the Cost of Ca…How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment (2010)How Medicare’s Payment Cuts F…Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting (2010)Cost Effectiveness of Evidenc…Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs (2009)Limits on Medicare's Ability …Male-Female Wage Differentials in Urban Labor Markets (1973)Male-Female Wage Differential…Delivery of Financial Navigation Services within National Cancer Institute-Designated Cancer Centers (2021)Delivery of Financial Navigat…Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis (2020)Women Who Are Young, Non-Whit…Understanding financial toxicity in head and neck cancer survivors (2019)Understanding financial toxic…The social and economic toll of cancer survivorship: a complex web of financial sacrifice (2019)The social and economic toll …Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey (2019)Rural-urban differences in fi…Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries (2017)Rising Prices of Targeted Ora…Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure (2016)Steady Increase In Prices For…Net Health Benefits (1998)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)The Shortage of Essential Chemotherapy Drugs in the United States (2011)The State of Cancer Care in America, 2014: A Report by the American Society of Clinical Oncology (2014)An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access (2021)Medical Bankruptcy in the United States, 2007: Results of a National Study (2009)The Price of Inequality (2013)Pricing in the Market for Anticancer Drugs (2015)Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval (2017)The Impact of Changing Medicare Reimbursement Rates on Physician-Induced Demand (1983)Physician response to fee changes with multiple payers (1991)Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer (2006)Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model (2014)Physicians Treating Physicians: Information and Incentives in Childbirth (2016)The price of innovation: new estimates of drug development costs (2003)Cancer Drugs in the United States: Justum Pretium—The Just Price (2013)Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity (2014)Five Years of Cancer Drug Approvals (2015)Pharmacy Benefits and the Use of Drugs by the Chronically Ill (2004)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Population-Based Assessment of Cancer Survivors' Financial Burden and Quality of Life: A Prospective Cohort Study (2015)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes (2019)Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis (2013)Financial Hardships Experienced by Cancer Survivors: A Systematic Review (2016)Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer (2016)Medical Financial Hardship among Cancer Survivors in the United States: What Do We Know? What Do We Need to Know? (2018)Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies (2019)Financial Toxicity in Advanced and Metastatic Cancer: Overburdened and Underprepared (2019)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors (2015)Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program (2020)Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States (2021)The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience (2013)Measuring financial toxicity as a clinically relevant patient‐reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) (2016)Potential impact of the COVID ‐19 pandemic on financial toxicity in cancer survivors (2020)Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis (2022)Human Capital, Effort, and the Sexual Division of Labor (1985)Labor Market Institutions and the Distribution of Wages, 1973-1992: A Semiparametric Approach (1996)The Gender Wage Gap: Extent, Trends, and Explanations (2017)Delivering affordable cancer care in high-income countries (2011)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Medical Care Costs Associated with Cancer Survivorship in the United States (2020)
this work references cited by second hop

References

  • 1973Male-Female Wage Differentials in Urban Labor Markets8,454 cited
  • 2011Projections of the Cost of Cancer Care in the United States: 2010-20202,653 cited
  • 2013The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts592 cited
  • 2013Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia500 cited
  • 2009Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs391 cited
  • 2010Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting173 cited
  • 2010How Medicare’s Payment Cuts For Cancer Chemotherapy Drugs Changed Patterns Of Treatment171 cited

Cited by

  • 2017Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries114 cited
  • 2019Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey102 cited
  • 2019Understanding financial toxicity in head and neck cancer survivors100 cited
  • 2019The social and economic toll of cancer survivorship: a complex web of financial sacrifice78 cited
  • 2020Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis78 cited
  • 2021

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Delivery of Financial Navigation Services within National Cancer Institute-Designated Cancer Centers
76 cited
  • 2016Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure75 cited